Why the study?
Current treatments for AF often do not achieve desired outcomes, and existing systematic reviews evaluating the effects of ACEIs and ARBs on AF prevention and cure have reported conflicting results.
Do ACEIs/ARBs prevent new-onset or secondary atrial fibrillation in various patient populations?
Do ACEIs/ARBs prevent new-onset or secondary atrial fibrillation in various patient populations?
Answers are grounded in this paper and cite their sources.
ACEIs/ARBs are effective for preventing new-onset and secondary AF in patients with heart failure or postoperatively, but not in those with hypertension or myocardial infarction.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: